A Canadian path to a regenerative cure to Type 1 diabetes

A Canadian company has developed a revolutionary way to improve the lives of those with diabetes

A Canadian path to a regenerative cure to Type 1 diabetesFor people living with diabetes, the hope for a functional cure remains 100 years after Dr. Frederick Banting’s breakthrough discovery of insulin. In answer to those hopes, a Canadian company has developed a revolutionary way to improve the lives of those with diabetes. Insulin remains the standard of care for people living with diabetes. The…

Measuring the risk of heart disease, diabetes in obese children

Type of cholesterol produced as food consumed a strong predictor of future health risk

University of Alberta researchers have found a new, more effective way to measure future heart disease and diabetes risk in youth. By testing the blood for remnant cholesterol (RC), made by the body during the day as food is consumed, researchers were able to show that this non-fasting type of cholesterol is a strong predictor…

Virtual clinic pilot sees success in rural Alberta community

U of A spinoff company launches MedROAD virtual clinic in Alberta, making long-distance health care a reality during COVID-19

Virtual clinic pilot sees success in rural Alberta communityA new pilot project called MedROAD is bringing the power of precision health to Pincher Creek, Alta. – and seeing promising results. MedROAD promises to be the future of telehealth, leveraging the power of artificial intelligence and cloud-based computing to remotely connect patients with health-care professionals, no matter where they are. Developed at the University of Alberta by computing scientist Pierre…

Twenty stories that defined the University of Alberta in 2020

In a year of unprecedented challenges, the people of the U of A gave us plenty of reasons to expect a brighter future

Twenty stories that defined the University of Alberta in 2020Let’s be honest: 2020 has been a tough year. Amid a global pandemic whose rising tide continues to take an enormous human and economic toll every day, it’s been hard to hold out hope for whatever the “new normal” might look like once COVID-19 finally ebbs for good. But through everything – including academic and…

Stem cell therapy research for Type 1 diabetes receives funding

Three U of A researchers will help lead projects to advance treatments for patients

Stem cell therapy research for Type 1 diabetes receives fundingUniversity of Alberta researchers are among two Canadian research teams chosen for significant new funding from the government of Canada and JDRF Canada to develop new stem cell-based therapies for treating Type 1 diabetes. The projects will each receive $1.5 million from the Canadian Institutes of Health Research Institute of Nutrition, Metabolism and Diabetes (CIHR-INMD), along with…

Diabetes research closer than ever to possible cure

As close to a cure for diabetes as we’re ever going to see

Diabetes research closer than ever to possible cureAs the world prepares to celebrate the 100th anniversary of the discovery of insulin next year, researchers at the University of Alberta are hard at work on what they hope will become the next big diabetes breakthrough. The project is led by James Shapiro, professor of surgery in the Faculty of Medicine & Dentistry and Canada Research…

Research opens new path for diagnosing and treating diabetes

Only a “proof of concept” at this stage, but validates the need for further research

Research opens new path for diagnosing and treating diabetesA team of researchers led by a University of Alberta pharmacology professor has mapped the function and gene expression of individual insulin-producing cells within the human pancreas, opening new paths of research for diagnosing and treating diabetes. “There’s been a lot of excitement the last few years about understanding how pancreatic beta cells make insulin,” said Patrick MacDonald,…

Type 2 diabetes drug buys time for a failing heart: study

The diabetes drug increased ketone levels, which might be the key to improving cardiac metabolism

Type 2 diabetes drug buys time for a failing heart: studyIn 2015, researchers began noticing that a drug used to treat Type 2 diabetes, empagliflozin, came with the added benefit of decreasing hospitalization for heart failure and death from cardiovascular causes in those patients. “It was very unexpected, because this drug is targeted and marketed for Type 2 diabetes, not heart failure,” said Kim Ho,…

Report card evaluates influences on children’s healthy food choices

Poor diet right behind tobacco consumption as leading cause of premature death for Canadians, says public health expert

Report card evaluates influences on children’s healthy food choicesEverything from advertising to school cafeteria menus can affect whether children develop lifelong healthy eating habits, according to the sixth annual Nutrition Report Card for Alberta. The report evaluates 39 indicators in five food “environments” – physical (what food is available?), economic (how affordable is healthy food?), communication (what messages are children getting about food through…

Patient-led movement creating better diabetes treatment

U of A PhD candidate studies and participates in grassroots movement to hack diabetes equipment

Patient-led movement creating better diabetes treatmentPeople with Type 1 diabetes – including University of Alberta graduate student Jonathan Garfinkel – are using free instructions from the Internet to build an artificial pancreas. The patient-led movement is pushing pharmaceutical companies to improve the treatments they offer, according to U of A diabetes expert Peter Light. “Diabetics have developed, programmed and are now living…